ReviewVirologica Sinica2015
Bacteriophage therapy against Enterobacteriaceae.
Review in Virologica Sinica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 37 citations in OpenAlex.
- The gut-kidney axis in high-altitude hypoxia: pathophysiological mechanisms and the central role of hypoxia inducible factor.Annals of medicine · 2025Review
- Preclinical characterization and in silico safety assessment of three virulent bacteriophages targeting carbapenem-resistant uropathogenic Escherichia coli.International microbiology : the official journal of the Spanish Society for Microbiology · 2024Article
- Characterizing the bacteriophage PKp-V1 as a potential treatment for ESBL-producing hypervirulent K1Veterinary world · 2024Article
- Fecal microbiota transplantation attenuates Escherichia coli infected outgrowth by modulating the intestinal microbiome.Microbial cell factories · 2023Article
- Isolation and characterization of novel bacteriophage vB_KpP_HS106 forFrontiers in microbiology · 2023Article
- Article
- Effect of aromatic oils on the expression of some virulence-associated and antimicrobial resistance genes ofJournal of advanced veterinary and animal research · 2022Article
- Detection of IMP-4 and SFO-1 co-producing ST51Frontiers in cellular and infection microbiology · 2022Article
- Article
- The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease.Journal of immunology research · 2021Review
- First Report of Coexistence ofFrontiers in microbiology · 2021Article
- Phages in Anaerobic Systems.Viruses · 2020Review
- Bacteriophage ZCSE2 is a Potent Antimicrobial AgainstViruses · 2020Article
- Genomic, Morphological and Functional Characterization of Virulent Bacteriophage IME-JL8 TargetingFrontiers in microbiology · 2020Article
- The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.Nature reviews. Nephrology · 2018Review
- Bacteriophage Clinical Use as Antibacterial "Drugs": Utility and Precedent.Microbiology spectrum · 2017Review
- Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures.Cell research · 2017Article
- Characterization and complete genome sequence of vB_EcoP-Bp4, a novel polyvalent N4-like bacteriophage that infects chicken pathogenic Escherichia coli.Virologica Sinica · 2016Article
- Characterization, Genome Sequence, and Analysis of Escherichia Phage CICC 80001, a Bacteriophage Infecting an Efficient L-Aspartic Acid Producing Escherichia coli.Food and environmental virology · 2016Article
- Morphological diversity of cultured cold-active lytic bacteriophages isolated from the Napahai plateau wetland in China.Virologica Sinica · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Enterobacteriaceae are a class of gram-negative facultative anaerobic rods, which can cause a variety of diseases, such as bacteremia, septic arthritis, endocarditis, osteomyelitis, lower respiratory tract infections, skin and soft-tissue infections, urinary tract infections, intra-abdominal infections and ophthalmic infections, in humans, poultry, animals and fish. Disease caused by Enterobacteriaceae cause the deaths of millions of people every year, resulting in enormous economic loss. Drug treatment is a useful and efficient way to control Enterobacteriaceae infections. However, with the abuse of antibiotics, drug resistance has been found in growing number of Enterobacteriaceae infections and, as such, there is an urgent need to find new methods of control. Bacteriophage therapy is an efficient alternative to antibiotics as it employs a different antibacterial mechanism. This paper summarizes the history of bacteriophage therapy, its bacterial lytic mechanisms, and the studies that have focused on Enterobacteriaceae and bacteriophage therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.